Allegheny Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Allegheny Financial Group's BIIB Position: Q2 2026 in Review
Allegheny Financial Group increased its Biogen (BIIB) stake by 1.5% in Q2 2026, buying an estimated $4.21K and bringing the position to 1,472 shares worth $318K. The position accounts for 0.03% of the portfolio, ranked #226.
Allegheny Financial Group first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. The position peaked at $663K in Q2 2024. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Allegheny Financial Group held 1,472 shares of Biogen worth $318K as of Q2 2026.
- Allegheny Financial Group bought 22 Biogen shares in Q2 2026, an estimated $4.21K.
- Biogen made up 0.03% of Allegheny Financial Group's portfolio in Q2 2026, its #226 holding.
- Allegheny Financial Group first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
- Allegheny Financial Group's Biogen position peaked at $663K in Q2 2024.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.